{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:23:56Z","timestamp":1792002236343,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["H2020-635408-PARAGONE"],"award-info":[{"award-number":["H2020-635408-PARAGONE"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["AGL2015-67023-C2-1-R"],"award-info":[{"award-number":["AGL2015-67023-C2-1-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fasciolosis is one of the most important parasitic diseases of livestock. The need for better control strategies gave rise to the identification of various vaccine candidates. The recombinant form of a member of the cysteine protease family, cathepsin L1 of\n                      <jats:italic>Fasciola hepatica<\/jats:italic>\n                      (FhCL1) has been a vaccine target for the past few decades since it has been shown to behave as an immunodominant antigen. However, when FhCL1 was used as vaccine, it has been observed to elicit significant protection in some trials, whereas no protection was provided in others.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In order to improve vaccine development strategy, we conducted a linear B-cell epitope mapping of FhCL1 in sheep vaccinated with FhCL1, FhHDM, FhLAP and FhPrx plus Montanide and with significant reduction of the fluke burden, sheep vaccinated with FhCL1, FhHDM, FhLAP and FhPrx plus aluminium hydroxide and with non-significant reduction of the fluke burden, and in unvaccinated-infected sheep.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study showed that the pattern and dynamic of peptide recognition varied noticeably between both vaccinated groups, and that the regions 55\u201363 and 77\u201384, which are within the propeptide, and regions 102\u2013114 and 265\u2013273 of FhCL1 were specifically recognised only by vaccinated sheep with significant reduction of the fluke burden. In addition, these animals also showed significant production of specific IgG2, whereas a scarce non-significant production was observed in animals vaccinated with Aluminium hydroxide and no production was detected in infected control animals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We have identified 42 residues of FhCL1 that contributed to protective immunity against infection with\n                      <jats:italic>F. hepatica<\/jats:italic>\n                      in sheep. Our results provide indications in relation to key aspects of the immune response. Given the variable outcomes of vaccination trials conducted in ruminants to date, this study adds new insights to improve strategies of vaccine development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-020-04260-6","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T08:03:58Z","timestamp":1596182638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2983-7288","authenticated-orcid":false,"given":"Leandro","family":"Buffoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Garza-Cuartero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"P\u00e9rez-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Zafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Javier Mart\u00ednez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Molina-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Mart\u00ednez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"4260_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ijpara.2005.07.010","volume":"35","author":"S Mas-Coma","year":"2005","unstructured":"Mas-Coma S, Bargues MD, Valero MA. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol. 2005;35:1255\u201378.","journal-title":"Int J Parasitol."},{"key":"4260_CR2","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1128\/IAI.00919-08","volume":"77","author":"CM Hamilton","year":"2009","unstructured":"Hamilton CM, Dowling DJ, Loscher CE, Morphew RM, Brophy PM, O\u2019Neill SM. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function. Infect Immun. 2009;77:2488\u201398.","journal-title":"Infect Immun."},{"key":"4260_CR3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/IAI.00573-09","volume":"78","author":"DJ Dowling","year":"2010","unstructured":"Dowling DJ, Hamilton CM, Donnelly S, La Course J, Brophy PM, Dalton J, et al. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect Immun. 2010;78:793\u2013801.","journal-title":"Infect Immun."},{"key":"4260_CR4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/eji.201545905","volume":"46","author":"A Aldridge","year":"2016","unstructured":"Aldridge A, O\u2019Neill SM. Fasciola hepatica tegumental antigens induce anergic-like T cells via dendritic cells in a mannose receptor-dependent manner. Eur J Immunol. 2016;46:1180\u201392.","journal-title":"Eur J Immunol."},{"key":"4260_CR5","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.1203011","volume":"190","author":"KV Vukman","year":"2013","unstructured":"Vukman KV, Adams PN, Metz M, Maurer M, O\u2019Neill SM. Fasciola hepatica tegumental coat impairs mast cells\u2019 ability to drive Th1 immune responses. J Immunol. 2013;190:2873\u20139.","journal-title":"J Immunol."},{"key":"4260_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vetpar.2013.04.008","volume":"195","author":"JP Dalton","year":"2013","unstructured":"Dalton JP, Robinson MW, Mulcahy G, O\u2019Neill SM, Donnelly S, O\u2019Neill SM, et al. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development. Vet Parasitol. 2013;195:272\u201385.","journal-title":"Vet Parasitol."},{"key":"4260_CR7","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1074\/mcp.M900045-MCP200","volume":"8","author":"MW Robinson","year":"2009","unstructured":"Robinson MW, Menon R, Donnelly SM, Dalton JP, Ranganathan S. An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host. Mol Cell Proteomics. 2009;8:1891\u2013907.","journal-title":"Mol Cell Proteomics"},{"key":"4260_CR8","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1074\/jbc.M708521200","volume":"283","author":"CM Stack","year":"2008","unstructured":"Stack CM, Caffrey CR, Donnelly SM, Seshaadri A, Lowther J, Tort JF, et al. Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica. J Biol Chem. 2008;283:9896\u2013908.","journal-title":"J Biol Chem."},{"key":"4260_CR9","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1074\/jbc.M308831200","volume":"279","author":"PR Collins","year":"2004","unstructured":"Collins PR, Stack CM, O\u2019Neill SM, Doyle S, Ryan T, Brennan GP, et al. Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propeptide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells. J Biol Chem. 2004;279:17038\u201346.","journal-title":"J Biol Chem."},{"key":"4260_CR10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0020-7519(01)00175-8","volume":"31","author":"JB Cornelissen","year":"2001","unstructured":"Cornelissen JB, Gaasenbeek CP, Borgsteede FH, Holland WG, Harmsen MM, Boersma WJ. Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease. Int J Parasitol. 2001;31:728\u201337.","journal-title":"Int J Parasitol."},{"key":"4260_CR11","doi-asserted-by":"crossref","first-page":"e2414","DOI":"10.1371\/journal.pntd.0002414","volume":"7","author":"B Gonzales Santana","year":"2013","unstructured":"Gonzales Santana B, Dalton JP, Vasquez Camargo F, Parkinson M, Ndao M. The diagnosis of human fascioliasis by enzyme-linked immunosorbent assay (ELISA) using recombinant cathepsin L protease. PLoS Negl Trop Dis. 2013;7:e2414.","journal-title":"PLoS Negl Trop Dis."},{"key":"4260_CR12","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1016\/j.vaccine.2010.06.039","volume":"28","author":"O Golden","year":"2010","unstructured":"Golden O, Flynn RJ, Read C, Sekiya M, Donnelly SM, Stack C, et al. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine. 2010;28:5551\u20137.","journal-title":"Vaccine"},{"key":"4260_CR13","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1128\/iai.64.12.5066-5074.1996","volume":"64","author":"JP Dalton","year":"1996","unstructured":"Dalton JP, McGonigle S, Rolph TP, Andrews SJ. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect Immun. 1996;64:5066\u201374.","journal-title":"Infect Immun."},{"key":"4260_CR14","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.vaccine.2019.04.067","volume":"37","author":"S Ortega-Vargas","year":"2019","unstructured":"Ortega-Vargas S, Espitia C, Sahag\u00fan-Ruiz A, Parada C, Balderas-Loaeza A, Villa-Mancera A, et al. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep. Vaccine. 2019;37:3234\u201340.","journal-title":"Vaccine"},{"key":"4260_CR15","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/IAI.67.4.1954-1961.1999","volume":"67","author":"L Piacenza","year":"1999","unstructured":"Piacenza L, Acosta D, Basmadjian I, Dalton JP, Carmona C. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Infect Immun. 1999;67:1954\u201361.","journal-title":"Infect Immun."},{"key":"4260_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00436-013-3650-6","volume":"113","author":"A Villa-Mancera","year":"2014","unstructured":"Villa-Mancera A, Reynoso-Palomar A, Utrera-Quintana F, Carre\u00f3n-Luna L. Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1\/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats. Parasitol Res. 2014;113:243\u201350.","journal-title":"Parasitol Res."},{"key":"4260_CR17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tvjl.2009.07.004","volume":"185","author":"RA P\u00e9rez-Ecija","year":"2010","unstructured":"P\u00e9rez-Ecija RA, Mendes RE, Zafra R, Buffonni L, Mart\u00ednez-Moreno A, P\u00e9rez J. Pathological and parasitological protection in goats immunised with recombinant cathepsin L1 and challenged with Fasciola hepatica. Vet J. 2010;185:351\u20133.","journal-title":"Vet J."},{"key":"4260_CR18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.apar.2019.01.001","volume":"104","author":"K Cwiklinski","year":"2019","unstructured":"Cwiklinski K, Donnelly S, Drysdale O, Jewhurst H, Smith D, De Marco Verissimo C, et al. The cathepsin-like cysteine peptidases of trematodes of the genus Fasciola. Adv Parasit. 2019;104:113\u201364.","journal-title":"Adv Parasit."},{"key":"4260_CR19","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1074\/mcp.M115.053934","volume":"14","author":"K Cwiklinski","year":"2015","unstructured":"Cwiklinski K, de la Torre-Escudero E, Trelis M, Bernal D, Dufresne PJ, Brennan GP, et al. The extracellular vesicles of the helminth pathogen, Fasciola hepatica: biogenesis pathways and cargo molecules involved in parasite pathogenesis. Mol Cell Proteomics. 2015;14:3258\u201373.","journal-title":"Mol Cell Proteomics."},{"key":"4260_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.vetpar.2011.09.027","volume":"185","author":"L Buffoni","year":"2012","unstructured":"Buffoni L, Mart\u00ednez-Moreno FJ, Zafra R, Mendes RE, P\u00e9rez-\u00c9cija A, Sekiya M, et al. Humoral immune response in goats immunised with cathepsin L1, peroxiredoxin and Sm14 antigen and experimentally challenged with Fasciola hepatica. Vet Parasitol. 2012;185:315\u201321.","journal-title":"Vet Parasitol."},{"key":"4260_CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetpar.2015.01.004","volume":"208","author":"V Molina-Hern\u00e1ndez","year":"2015","unstructured":"Molina-Hern\u00e1ndez V, Mulcahy G, P\u00e9rez J, Mart\u00ednez-Moreno A, Donnelly S, O\u2019Neill SM, et al. Fasciola hepatica vaccine: we may not be there yet but we\u2019re on the right road. Vet Parasitol. 2015;208:101\u201311.","journal-title":"Vet Parasitol."},{"key":"4260_CR22","doi-asserted-by":"crossref","unstructured":"Torres D, Espino AM. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family. Infect Immun. 2006;74:4932\u20138.","DOI":"10.1128\/IAI.00442-06"},{"key":"4260_CR23","doi-asserted-by":"crossref","unstructured":"Sexton JL, Wilce MC, Colin T, Wijffels GL, Salvatore L, Feil S, et al. Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen. J Immunol. 1994;152:1861\u201372.","DOI":"10.4049\/jimmunol.152.4.1861"},{"key":"4260_CR24","doi-asserted-by":"crossref","first-page":"e0188520","DOI":"10.1371\/journal.pone.0188520","volume":"12","author":"V Mart\u00ednez-Sern\u00e1ndez","year":"2017","unstructured":"Mart\u00ednez-Sern\u00e1ndez V, Perteguer MJ, Mezo M, Gonz\u00e1lez-Warleta M, G\u00e1rate T, Valero MA, et al. Fasciola spp: mapping of the MF6 epitope and antigenic analysis of the MF6p\/HDM family of heme-binding proteins. PLoS ONE. 2017;12:e0188520.","journal-title":"PLoS ONE."},{"key":"4260_CR25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijpara.2003.12.011","volume":"34","author":"MM Harmsen","year":"2004","unstructured":"Harmsen MM, Cornelissen JB, Buijs HE, Boersma WJ, Jeurissen SH, van Milligen FJ. Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide. Int J Parasitol. 2004;34:675\u201382.","journal-title":"Int J Parasitol."},{"key":"4260_CR26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.vaccine.2018.01.020","volume":"36","author":"L Garza-Cuartero","year":"2018","unstructured":"Garza-Cuartero L, Geurden T, Mahan SM, Hardham JM, Dalton JP, Mulcahy G. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and\/or vaccinated cattle and identification of protective linear B-cell epitopes. Vaccine. 2018;36:958\u201368.","journal-title":"Vaccine."},{"key":"4260_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tvjl.2012.03.003","volume":"194","author":"A Villa-Mancera","year":"2012","unstructured":"Villa-Mancera A, M\u00e9ndez-Mendoza M. Protection and antibody isotype responses against Fasciola hepatica with specific antibody to pIII-displayed peptide mimotopes of cathepsin L1 in sheep. Vet J. 2012;194:108\u201312.","journal-title":"Vet J."},{"key":"4260_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1432-1033.1997.t01-1-00373.x","volume":"245","author":"L Roche","year":"1997","unstructured":"Roche L, Dowd AJ, Tort J, McGonigle S, McSweeney A, Curley GP, et al. Functional expression of Fasciola hepatica cathepsin L1 in Saccharomyces cerevisiae. Eur J Biochem. 1997;245:373\u201380.","journal-title":"Eur J Biochem."},{"key":"4260_CR29","doi-asserted-by":"crossref","unstructured":"Robinson MW, Donnelly S, Hutchinson AT, To J, Taylor NL, Norton RS, el at. A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog. 2011;7:e1002042.","DOI":"10.1371\/journal.ppat.1002042"},{"key":"4260_CR30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbiopara.2007.11.011","volume":"158","author":"D Acosta","year":"2008","unstructured":"Acosta D, Cancela M, Piacenza L, Roche L, Carmona C, Tort JF. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis. Mol Biochem Parasit. 2008;158:52\u20134.","journal-title":"Mol Biochem Parasit."},{"key":"4260_CR31","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1016\/j.febslet.2006.08.019","volume":"580","author":"M Sekiya","year":"2006","unstructured":"Sekiya M, Mulcahy G, Irwin JA, Stack CM, Donnelly SM, Xu W, et al. Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica. FEBS Lett. 2006;580:5016\u201322.","journal-title":"FEBS Lett."},{"key":"4260_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3284308","volume":"83","author":"P Berasa\u00edn","year":"1997","unstructured":"Berasa\u00edn P, Go\u00f1i F, McGonigle S, Dowd A, Dalton JP, Frangione B, et al. Proteinases secreted by Fasciola hepatica degrade extracellular matrix and basement membrane components. J Parasitol. 1997;83:1\u20135.","journal-title":"J Parasitol."},{"key":"4260_CR33","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1074\/jbc.M109.060368","volume":"285","author":"S Donnelly","year":"2010","unstructured":"Donnelly S, O\u2019Neill SM, Stack CM, Robinson MW, Turnbull L, Whitchurch C, et al. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem. 2010;285:3383\u201392.","journal-title":"J Biol Chem."},{"key":"4260_CR34","doi-asserted-by":"crossref","unstructured":"Coakley G, McCaskill JL, Borger JG, Simbari F, Robertson E1, Millar M, et al. Extracellular vesicles from a helminth parasite suppress macrophage activation and constitute an effective vaccine for protective immunity. Cell Rep. 2017;19:1545\u201357.","DOI":"10.1016\/j.celrep.2017.05.001"},{"key":"4260_CR35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0264-410X(97)00289-2","volume":"16","author":"G Mulcahy","year":"1998","unstructured":"Mulcahy G, O\u2019Connor F, McGonigle S, Dowd A, Clery DG, Andrews SJ, et al. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine. 1998;16:932\u20139.","journal-title":"Vaccine"},{"key":"4260_CR36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/rvsc.1998.0270","volume":"67","author":"G Mulcahy","year":"1999","unstructured":"Mulcahy G, O\u2019Connor F, Clery D, Hogan SF, Dowd AJ, Andrews SJ, et al. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines. Res Vet Sci. 1999;67:27\u201333.","journal-title":"Res Vet Sci."},{"key":"4260_CR37","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3389\/fimmu.2018.02406","volume":"9","author":"E Varela-Mart\u00ednez","year":"2018","unstructured":"Varela-Mart\u00ednez E, Abenda\u00f1o N, As\u00edn J, Sistiaga-Poveda M, P\u00e9rez MM, Reina R, et al. molecular signature of aluminum hydroxide adjuvant in ovine PBMCs by integrated mRNA and microRNA transcriptome sequencing. Front Immunol. 2018;9:2406.","journal-title":"Front Immunol."},{"key":"4260_CR38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40064-015-0972-0","volume":"4","author":"TR Ghimire","year":"2015","unstructured":"Ghimire TR. The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm. Springerplus. 2015;4:181.","journal-title":"Springerplus."},{"key":"4260_CR39","doi-asserted-by":"crossref","unstructured":"Rojas-Caraballo J, L\u00f3pez-Ab\u00e1n J, P\u00e9rez del Villar L, Vizca\u00edno C, Vicente B, Fern\u00e1ndez-Soto P, et al. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes. PLoS ONE 2014;9:e105323.","DOI":"10.1371\/journal.pone.0105323"},{"key":"4260_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0145-2126(84)90070-5","volume":"8","author":"C Bruck","year":"1984","unstructured":"Bruck C, Portetelle D, Mammerickx M, Mathot S, Burny A. Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep. Leuk Res. 1984;8:315\u201321.","journal-title":"Leuk Res."},{"key":"4260_CR41","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-3083.1996.d01-332.x","volume":"44","author":"RA Collins","year":"1996","unstructured":"Collins RA, Sopp P, Gelder KI, Morrison WI, Howard CJ. Bovine gamma\/delta TcR+ T lymphocytes are stimulated to proliferate by autologous Theileria annulata-infected cells in the presence of interleukin-2. Scand J Immunol. 1996;44:444\u201352.","journal-title":"Scand J Immunol."},{"key":"4260_CR42","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.1003599","volume":"186","author":"FN Toka","year":"2011","unstructured":"Toka FN, Kenney MA, Golde WT. Rapid and transient activation of \u03b3\u03b4 T cells to IFN-\u03b3 production, NK cell-like killing, and antigen processing during acute virus infection. J Immunol. 2011;186:4853\u201361.","journal-title":"J Immunol."},{"key":"4260_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3024.1999.00188.x","volume":"21","author":"DF McCole","year":"1999","unstructured":"McCole DF, Doherty ML, Baird AW, Davies WC, McGill K, Torgerson PR. T cell subset involvement in immune responses to Fasciola hepatica infection in cattle. Parasite Immunol. 1999;21:1\u20138.","journal-title":"Parasite Immunol."},{"key":"4260_CR44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/s13071-018-3250-5","volume":"11","author":"R P\u00e9rez-Caballero","year":"2018","unstructured":"P\u00e9rez-Caballero R, Javier Mart\u00ednez-Moreno F, Zafra R, Molina-Hern\u00e1ndez V, Pacheco IL, Teresa Ruiz-Campillo M, et al. Comparative dynamics of peritoneal cell immunophenotypes in sheep during the early and late stages of the infection with Fasciola hepatica by flow cytometric analysis. Parasit Vectors. 2018;11:640.","journal-title":"Parasit Vectors"},{"key":"4260_CR45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0804482","volume":"77","author":"KK Lahmers","year":"2005","unstructured":"Lahmers KK, Norimine J, Abrahamsen MS, Palmer GH, Brown WC. The CD4+ T cell immunodominant Anaplasma marginale major surface protein 2 stimulates gammadelta T cell clones that express unique T cell receptors. J Leukoc Biol. 2005;77:199\u2013208.","journal-title":"J Leukoc Biol."},{"key":"4260_CR46","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.1302567","volume":"192","author":"JL McGill","year":"2014","unstructured":"McGill JL, Sacco RE, Baldwin CL, Telfer JC, Palmer MV, Waters WR. Specific recognition of mycobacterial protein and peptide antigens by \u03b3\u03b4 T cell subsets following infection with virulent Mycobacterium bovis. J Immunol. 2014;192:2756\u201369.","journal-title":"J Immunol."},{"key":"4260_CR47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cvfa.2019.08.001","volume":"35","author":"M Guerra-Maupome","year":"2019","unstructured":"Guerra-Maupome M, Slate JR, McGill JL. Gamma delta T cell function in ruminants. Vet Clin North Am Food Anim Pract. 2019;35:453\u201369.","journal-title":"Vet Clin North Am Food Anim Pract."},{"key":"4260_CR48","doi-asserted-by":"crossref","first-page":"e0005015","DOI":"10.1371\/journal.pntd.0005015","volume":"10","author":"Y Fu","year":"2016","unstructured":"Fu Y, Chryssafidis AL, Browne JA, O\u2019Sullivan J, McGettigan PA, Mulcahy G. transcriptomic study on ovine immune responses to Fasciola hepatica infection. PLoS Negl Trop Dis. 2016;10:e0005015.","journal-title":"PLoS Negl Trop Dis."},{"key":"4260_CR49","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3389\/fimmu.2019.02081","volume":"10","author":"A Garc\u00eda-Campos","year":"2019","unstructured":"Garc\u00eda-Campos A, Correia CN, Naranjo-Lucena A, Garza-Cuartero L, Farries G, Browne JA, et al. Fasciola hepatica infection in cattle: analyzing responses of peripheral blood mononuclear cells (PBMC) using a transcriptomics approach. Front Immunol. 2019;10:2081.","journal-title":"Front Immunol."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04260-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-020-04260-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04260-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T23:57:19Z","timestamp":1696463839000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-04260-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4260"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-04260-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-28171\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-28171\/v2","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This experiment was performed in accordance with the Spanish (L32\/2007 and RD53\/2013) and the European Union regulations (Directive 2010\/63\/EU). The procedure was approved by the University of Cordoba Bioethics Committee (code no. 1118).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"390"}}